CIM Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,300
Closed -$222K 277
2021
Q4
$222K Buy
+2,300
New +$222K 0.07% 268
2021
Q3
Sell
-3,454
Closed -$283K 315
2021
Q2
$283K Buy
+3,454
New +$283K 0.09% 222
2021
Q1
Sell
-3,921
Closed -$243K 312
2020
Q4
$243K Hold
3,921
0.08% 237
2020
Q3
$233K Buy
3,921
+58
+2% +$3.45K 0.09% 214
2020
Q2
$270K Buy
+3,863
New +$270K 0.11% 181
2020
Q1
Sell
-3,206
Closed -$209K 220
2019
Q4
$209K Sell
3,206
-2,509
-44% -$164K 0.08% 203
2019
Q3
$355K Hold
5,715
0.13% 192
2019
Q2
$407K Sell
5,715
-112
-2% -$7.98K 0.15% 162
2019
Q1
$457K Buy
5,827
+2,417
+71% +$190K 0.18% 143
2018
Q4
$289K Buy
+3,410
New +$289K 0.13% 217
2017
Q4
Sell
-4,166
Closed -$354K 331
2017
Q3
$354K Sell
4,166
-4,174
-50% -$355K 0.13% 224
2017
Q2
$632K Sell
8,340
-262
-3% -$19.9K 0.22% 111
2017
Q1
$568K Hold
8,602
0.2% 137
2016
Q4
$545K Hold
8,602
0.2% 143
2016
Q3
$548K Buy
8,602
+337
+4% +$21.5K 0.21% 125
2016
Q2
$615K Buy
+8,265
New +$615K 0.25% 111
2016
Q1
Sell
-4,894
Closed -$331K 279
2015
Q4
$331K Hold
4,894
0.15% 160
2015
Q3
$261K Buy
4,894
+585
+14% +$31.2K 0.13% 187
2015
Q2
$271K Sell
4,309
-4,314
-50% -$271K 0.12% 182
2015
Q1
$415K Hold
8,623
0.18% 141
2014
Q4
$286K Buy
8,623
+1,193
+16% +$39.6K 0.13% 167
2014
Q3
$218K Buy
+7,430
New +$218K 0.11% 166